The human genome project,predictive testing and insurance contracts: Ethical and legal responses |
| |
Authors: | Ruth Chadwick Charles Ngwena |
| |
Affiliation: | (1) Centre for Professional Ethics, University of Central Lancashire, UK;(2) Department of Law, University of Swaziland, Switzerland |
| |
Abstract: | Conclusion The economic costs to the insurers of complementary routine genetic testing would outweigh the benefits. However, should testing technology in future be refined so as to produce a cheap and reliable test, there is no reason why insurers might not take up predictive testing as part of the normal underwriting process. It is this possibility which justifies formulating a pre-emptive policy. At the very least, there are reasons for promoting and protecting the welfare of the proposer so as to redress the bargaining positions between him or her as a consumer of a service and the insurer as a commercial concern. Further considerations relate to the social purpose of insurance as a social mechanism, and the need to find ways of avoiding undermining this in light of Human Genome Project. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|